Aytu BioPharma entered into an agreement with AMT Manufacturing Solutions, a newly established, full service Contract Manufacturing Organization, to sublease 22,909 square feet of Aytu‘s Grand Prairie, TX manufacturing facility. This sublease represents over 30% of the Company’s FDA and DEA-approved pharmaceutical manufacturing facility. In addition, commencing as early as April 1, 2024, but no later than December 31, 2024, the sublease will be expanded to include the rest of the manufacturing facility, a total of 77,112 square feet.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AYTU:
